Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Protein Engineering
|
July 1, 1988
Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30
J Markussen, I Diers, P Hougaard, et al.
Diabetologia
|
September 1, 1991
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients
M A Gall, P Rossing, P Skøtt, et al.
Journal of Diabetes and Its Complications
|
December 20, 2000
A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood
B S Olsen, A Sjølie, P Hougaard, et al.
Protein Engineering
|
June 1, 1987
Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30
J Markussen, I Diers, A Engesgaard, et al.
Pediatric Diabetes
|
August 28, 2009
Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis
Henrik B Mortensen, Peter G F Swift, Reinhard W Holl, et al.
Clinical Immunology (Orlando, Fla.)
|
April 25, 2008
Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes
C Pfleger, A Kaas, L Hansen, et al.
Diabetologia
|
November 25, 2005
Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function
L B Nielsen, H B Mortensen, F Chiarelli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 31, 2016
Increased mortality in a Danish cohort of young people with Type 1 diabetes mellitus followed for 24 years
K Sandahl, L B Nielsen, J Svensson, et al.
Diabetes & Metabolism
|
April 13, 2016
Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial
R M Agesen, P L Kristensen, H Beck-Nielsen, et al.
Diabetes Care
|
July 27, 2001
Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group
T Danne, H B Mortensen, P Hougaard, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Protein Engineering
|
July 1, 1988
Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30
J Markussen, I Diers, P Hougaard, et al.
Diabetologia
|
September 1, 1991
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients
M A Gall, P Rossing, P Skøtt, et al.
Journal of Diabetes and Its Complications
|
December 20, 2000
A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood
B S Olsen, A Sjølie, P Hougaard, et al.
Protein Engineering
|
June 1, 1987
Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30
J Markussen, I Diers, A Engesgaard, et al.
Pediatric Diabetes
|
August 28, 2009
Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis
Henrik B Mortensen, Peter G F Swift, Reinhard W Holl, et al.
Clinical Immunology (Orlando, Fla.)
|
April 25, 2008
Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes
C Pfleger, A Kaas, L Hansen, et al.
Diabetologia
|
November 25, 2005
Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function
L B Nielsen, H B Mortensen, F Chiarelli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 31, 2016
Increased mortality in a Danish cohort of young people with Type 1 diabetes mellitus followed for 24 years
K Sandahl, L B Nielsen, J Svensson, et al.
Diabetes & Metabolism
|
April 13, 2016
Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial
R M Agesen, P L Kristensen, H Beck-Nielsen, et al.
Diabetes Care
|
July 27, 2001
Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group
T Danne, H B Mortensen, P Hougaard, et al.
Page
of 7